LEN, which is mainly catalyzed by CYP3A, is used to treat various cancers, including hepatocellular carcinoma, thyroid cancer, endometrial cancer, and renal cell carcinoma.1, 2, 3, 4, 5, 21. Here, CYP3A4 is linked to hereditary clear cell renal cell carcinoma.